These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 12144123)

  • 1. Plasma endothelin-1 levels and albumin excretion rate in normotensive, microalbuminuric type 2 diabetic patients.
    Bruno CM; Meli S; Marcinno M; Ierna D; Sciacca C; Neri S
    J Biol Regul Homeost Agents; 2002; 16(2):114-7. PubMed ID: 12144123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Albuminuria and 24-h ambulatory blood pressure in normoalbuminuric and microalbuminuric NIDDM patients. A longitudinal study.
    Nielsen S; Schmitz A; Poulsen PL; Hansen KW; Mogensen CE
    Diabetes Care; 1995 Nov; 18(11):1434-41. PubMed ID: 8722066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relation between plasma endothelin-1 levels and metabolic control, risk factors, treatment modalities, and diabetic microangiopathy in patients with Type 2 diabetes mellitus.
    Ak G; Buyukberber S; Sevinc A; Turk HM; Ates M; Sari R; Savli H; Cigli A
    J Diabetes Complications; 2001; 15(3):150-7. PubMed ID: 11358684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma brain natriuretic peptide levels in normotensive noninsulin-dependent diabetic patients with microalbuminuria.
    Yano Y; Katsuki A; Gabazza EC; Ito K; Fujii M; Furuta M; Tuchihashi K; Goto H; Nakatani K; Hori Y; Sumida Y; Adachi Y
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2353-6. PubMed ID: 10404802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cerivastatin on urinary albumin excretion and plasma endothelin-1 concentrations in type 2 diabetes patients with microalbuminuria and dyslipidemia.
    Nakamura T; Ushiyama C; Hirokawa K; Osada S; Shimada N; Koide H
    Am J Nephrol; 2001; 21(6):449-54. PubMed ID: 11799261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between lipoprotein profile and urinary albumin excretion in type II diabetic patients with stable metabolic control.
    Reverter JL; Sentí M; Rubiés-Prat J; Lucas A; Salinas I; Pizarro E; Pedro-Botet J; Romero R; Sanmartí A
    Diabetes Care; 1994 Mar; 17(3):189-94. PubMed ID: 8174446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia.
    Ravid M; Brosh D; Ravid-Safran D; Levy Z; Rachmani R
    Arch Intern Med; 1998 May; 158(9):998-1004. PubMed ID: 9588433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcapillary escape rate of albumin in type II diabetic patients. The relationship with microalbuminuria and hypertension.
    Nannipieri M; Penno G; Rizzo L; Pucci L; Bandinelli S; Mattei P; Taddei S; Salvetti A; Navalesi R
    Diabetes Care; 1997 Jun; 20(6):1019-26. PubMed ID: 9167118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum and urinary nitric oxide in Type 2 diabetes with or without microalbuminuria: relation to glomerular hyperfiltration.
    Apakkan Aksun S; Ozmen B; Ozmen D; Parildar Z; Senol B; Habif S; Mutaf I; Turgan N; Bayindir O
    J Diabetes Complications; 2003; 17(6):343-8. PubMed ID: 14583179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of pioglitazone, glibenclamide, and voglibose on urinary endothelin-1 and albumin excretion in diabetes patients.
    Nakamura T; Ushiyama C; Shimada N; Hayashi K; Ebihara I; Koide H
    J Diabetes Complications; 2000; 14(5):250-4. PubMed ID: 11113686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of pentoxifylline with angiotensin converting enzyme inhibitors produces an additional reduction in microalbuminuria in hypertensive type 2 diabetic patients.
    Harmankaya O; Seber S; Yilmaz M
    Ren Fail; 2003 May; 25(3):465-70. PubMed ID: 12803510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelin-1 levels and albuminuria in patients with type 2 diabetes mellitus.
    Zanatta CM; Gerchman F; Burttet L; Nabinger G; Jacques-Silva MC; Canani LH; Gross JL
    Diabetes Res Clin Pract; 2008 May; 80(2):299-304. PubMed ID: 18346810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Value of Serum Prolidase Activity in Progression of Microalbuminuria in Patients With Type 2 Diabetes Mellitus.
    Sabuncu T; Boduroglu O; Eren MA; Torun AN; Aksoy N
    J Clin Lab Anal; 2016 Sep; 30(5):557-62. PubMed ID: 26666214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal functional reserve in IDDM patients.
    Sackmann H; Tran-Van T; Tack I; Hanaire-Broutin H; Tauber JP; Ader JL
    Diabetologia; 1998 Jan; 41(1):86-93. PubMed ID: 9498635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary albumin excretion rate and its determinants after 6 years in non-insulin-dependent diabetic patients.
    Wirta OR; Pasternack AI; Mustonen JT; Koivula TA; Harmoinen A
    Nephrol Dial Transplant; 1996 Mar; 11(3):449-56. PubMed ID: 8671814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma angiotensin II, renin activity and serum angiotensin-converting enzyme activity in non-insulin dependent diabetes mellitus patients with diabetic nephropathy.
    Nicola W; Sidhom G; El Khyat Z; Ibrahim S; Salah A; El Sayed A
    Endocr J; 2001 Feb; 48(1):25-31. PubMed ID: 11403100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma endothelin in NIDDM patients with and without complications.
    Bertello P; Veglio F; Pinna G; Gurioli L; Molino P; Alban S; Chiandussi L
    Diabetes Care; 1994 Jun; 17(6):574-7. PubMed ID: 8082527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of plasma and urinary endothelin-1 in early diabetic and hypertensive nephropathy.
    De Mattia G; Cassone-Faldetta M; Bellini C; Bravi MC; Laurenti O; Baldoncini R; Santucci A; Ferri C
    Am J Hypertens; 1998 Aug; 11(8 Pt 1):983-8. PubMed ID: 9715792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased plasma levels of endothelin 1 and von Willebrand factor in patients with type 2 diabetes and dyslipidemia.
    Seligman BG; Biolo A; Polanczyk CA; Gross JL; Clausell N
    Diabetes Care; 2000 Sep; 23(9):1395-400. PubMed ID: 10977040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function.
    Chen CC; Susanto H; Chuang WH; Liu TY; Wang CH
    Cardiovasc Diabetol; 2016 Jan; 15():3. PubMed ID: 26739836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.